Historical source coverage

2024, page 2

273 selected records with a cited source date in 2024, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2024 by record type

3 types

April 2024

25 records on this page

Literature metadata · LL-37

[Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37].

PubMed lists PMID 38604693 in Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control as Review, English Abstract, Journal Article, with publication-date metadata of 2024-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Gallium Ga 68 dotatate

The lesion detection rate of Ga-68 DOTATATE PET/MR in multiple endocrine neoplasia type 1.

PubMed lists PMID 38563291 in Journal of medical imaging and radiation oncology as Journal Article, with publication-date metadata of 2024-04-02 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Leuprolide

Federal Register notice 2024-08657

The Federal Register published notice 2024-08657, attributed to FDA and its parent HHS department, on 2024-04-23. Its official title is “PAI Holdings, LLC DBA Pharmaceutical Associates, Inc., et al.; Withdrawal of Approval of 23 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT04522622

PeptideScanner retained ClinicalTrials.gov record NCT04522622 at 2026-07-30T18:46:20.407Z. Its registry update date was 2024-04-23, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT03098797

PeptideScanner retained ClinicalTrials.gov record NCT03098797 at 2026-07-30T18:46:20.414Z. Its registry update date was 2024-04-16, and PeptideScanner's reviewed identity mapping was elamipretide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Degarelix

Evaluation of degarelix in the management of prostate cancer.

PubMed lists PMID 21188095 in Cancer management and research as Journal Article, with publication-date metadata of 2010-01-25 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Melanotan II

5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.

PubMed lists PMID 38285527 in Chemistry (Weinheim an der Bergstrasse, Germany) as Journal Article, with publication-date metadata of 2024-02-15 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Zilucoplan

Zilucoplan (Zilbrysq) for myasthenia gravis.

PubMed lists PMID 38576149 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2024-04-15 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

March 2024

31 records on this page

Literature metadata · Abaloparatide

Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density.

PubMed lists PMID 33638863 in Clinical drug investigation as Clinical Trial, Phase I, Journal Article, with publication-date metadata of 2021-02-27 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Icatibant

Review of icatibant use in the Winnipeg Regional Health Authority.

PubMed lists PMID 33292436 in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology as Journal Article, with publication-date metadata of 2020-11-11 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Elamipretide

Mitochondrial protein interaction landscape of SS-31.

PubMed lists PMID 32554501 in Proceedings of the National Academy of Sciences of the United States of America as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-06-17 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide.

PubMed lists PMID 29184433 in International journal of general medicine as Journal Article, Review, with publication-date metadata of 2017-10-31 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.

PubMed lists PMID 28615947 in Therapeutics and clinical risk management as Journal Article, Review, with publication-date metadata of 2017-06-01 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Ganirelix

Molecular characterization, modeling, in silico analysis of equine pituitary gonadotropin alpha subunit and docking interaction studies with ganirelix.

PubMed lists PMID 28721542 in In silico pharmacology as Journal Article, with publication-date metadata of 2017-07-18 (day precision). PeptideScanner associated the retained record with the identity slug ganirelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Metreleptin

New advances in the treatment of generalized lipodystrophy: role of metreleptin.

PubMed lists PMID 26396524 in Therapeutics and clinical risk management as Journal Article, Review, with publication-date metadata of 2015-09-16 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Daptomycin as an option for lock therapy: a systematic literature review.

PubMed lists PMID 37622290 in Future microbiology as Journal Article, Systematic Review, with publication-date metadata of 2023-08-25 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · PEG-MGF

Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?

PubMed lists PMID 23125840 in Frontiers in endocrinology as Journal Article, with publication-date metadata of 2012-11-01 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Terlipressin

Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation.

PubMed lists PMID 32574418 in Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society as Journal Article, Review, with publication-date metadata of 2020-08-09 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT04103034

PeptideScanner retained ClinicalTrials.gov record NCT04103034 at 2026-11-16T01:33:21.554Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Kisspeptin-10

Immature rat seminal vesicles show histomorphological and ultrastructural alterations following treatment with kisspeptin-10.

PubMed lists PMID 22404961 in Reproductive biology and endocrinology : RB&E as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-03-10 (day precision). PeptideScanner associated the retained record with the identity slug kisspeptin-10. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT06303284

PeptideScanner retained ClinicalTrials.gov record NCT06303284 at 2026-07-30T18:47:17.466Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Triptorelin

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer.

PubMed lists PMID 29551913 in Breast cancer (Dove Medical Press) as Journal Article, Review, with publication-date metadata of 2018-03-06 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.

PubMed lists PMID 29440923 in International journal of nephrology and renovascular disease as Journal Article, Review, with publication-date metadata of 2018-02-05 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Elamipretide

Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide.

PubMed lists PMID 29951944 in Cardiovascular drugs and therapy as Journal Article, with publication-date metadata of 2018-08 (month precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · TB-500

PubMed record PMID 38382158

PeptideScanner retained PubMed bibliographic metadata for PMID 38382158 at 2026-07-30T18:48:13.580Z. PubMed recorded a metadata revision date of 2024-03-11 and an Entrez history date of 2024-02-21. PeptideScanner associated this retained record with the identity slug tb-500. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Dalbavancin

Dalba Got Back? Use of Dalbavancin for the Treatment of Vertebral Osteomyelitis.

PubMed lists PMID 38449918 in Open forum infectious diseases as Clinical Trial, Journal Article, with publication-date metadata of 2024-02-07 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Acute and Severe Hypercalcemia Early After Kidney Transplantation in a Patient Previously Treated With Etelcalcetide.

PubMed lists PMID 37383843 in Transplant international : official journal of the European Society for Organ Transplantation as Journal Article, with publication-date metadata of 2023-06-13 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Mazdutide

PubMed record PMID 38440786

PeptideScanner retained PubMed bibliographic metadata for PMID 38440786 at 2026-07-30T18:48:13.638Z. PubMed recorded a metadata revision date of 2024-03-07 and an Entrez history date of 2024-03-05. PeptideScanner associated this retained record with the identity slug mazdutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Regulatory · Vosoritide

Federal Register notice 2024-04479

The Federal Register published notice 2024-04479, attributed to FDA and its parent HHS department, on 2024-03-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VOXZOGO,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide.

Source: Federal Register via GovInfo ↗

→

February 2024

11 records on this page

Regulatory · Tirzepatide

Federal Register notice 2024-04157

The Federal Register published notice 2024-04157, attributed to FDA and its parent HHS department, on 2024-02-29. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; MOUNJARO,” and PeptideScanner's exact reviewed identity mapping connects the document to Tirzepatide.

Source: Federal Register via GovInfo ↗

→

Regulatory · Leuprolide

Federal Register notice 2024-04218

The Federal Register published notice 2024-04218, attributed to FDA and its parent HHS department, on 2024-02-29. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; CAMCEVI,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Mecasermin

ClinicalTrials.gov record NCT02636270

PeptideScanner retained ClinicalTrials.gov record NCT02636270 at 2026-11-16T17:35:13.282Z. Its registry update date was 2024-02-28, and PeptideScanner's reviewed identity mapping was mecasermin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tesofensine

ClinicalTrials.gov record NCT03149445

PeptideScanner retained ClinicalTrials.gov record NCT03149445 at 2026-11-16T17:29:46.323Z. Its registry update date was 2024-02-26, and PeptideScanner's reviewed identity mapping was tesofensine.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Cerebrolysin

ClinicalTrials.gov record NCT00947531

PeptideScanner retained ClinicalTrials.gov record NCT00947531 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-02-21, and PeptideScanner's reviewed identity mapping was cerebrolysin.

Source: ClinicalTrials.gov ↗

→

Regulatory · Terlipressin

Federal Register notice 2024-03300

The Federal Register published notice 2024-03300, attributed to FDA and its parent HHS department, on 2024-02-16. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Terlipressin.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT04081337

PeptideScanner retained ClinicalTrials.gov record NCT04081337 at 2026-07-30T18:48:25.645Z. Its registry update date was 2024-02-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glatiramer acetate

Interferon beta and glatiramer acetate therapy.

PubMed lists PMID 23264098 in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-01 (month precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

January 2024

6 records on this page

Clinical trials · Difelikefalin

ClinicalTrials.gov record NCT03617536

PeptideScanner retained ClinicalTrials.gov record NCT03617536 at 2026-11-15T21:56:33.343Z. Its registry update date was 2024-01-24, and PeptideScanner's reviewed identity mapping was difelikefalin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT04407234

PeptideScanner retained ClinicalTrials.gov record NCT04407234 at 2026-07-30T18:49:14.741Z. Its registry update date was 2024-01-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→